Functional screening implicates miR-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs

Acquired resistance to cancer drug therapies almost always occurs in advanced-stage patients even following a significant response to treatment. In addition to mutational mechanisms, various non-mutational resistance mechanisms have now been recognized. We previously described a chromatin-mediated s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Nisebita, Stephan, Jean-Philippe, Cruz, Darlene Dela, Merchant, Mark, Haley, Benjamin, Bourgon, Richard, Classon, Marie, Settleman, Jeff
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976141/
https://www.ncbi.nlm.nih.gov/pubmed/27484502
http://dx.doi.org/10.1038/ncomms12351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976141/
https://www.ncbi.nlm.nih.gov/pubmed/27484502
http://dx.doi.org/10.1038/ncomms12351

Ejemplares similares